StonvexLoading…
StonvexStonvexStonvexCore line items from SAFE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $110.85M | $385.55M | $287.68M | $191.52M |
Operating Income | $25.55M | $100.90M | $74.10M | $49.22M |
Net Income | $28.86M | $114.47M | $86.59M | $57.31M |
EPS (Diluted) | $0.40 | $1.59 | $1.21 | $0.80 |
Total Assets | $7.38B | $7.25B | $7.15B | $7.06B |
Total Liabilities | $4.92B | $4.81B | $4.73B | $4.66B |
Cash & Equivalents | $19.30M | $21.70M | $12.12M | $13.91M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 71.82M | 71.76M | 71.76M | 71.76M |